Newsletters

April 2025 Newsletter

Press Releases

April 21, 2025 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) today announced the release of a new Equine Health Advisory identifying key risk factors associated with fatal proximal forelimb fractures in Thoroughbreds. The advisory, which is based on data drawn from the HISA Portal, provides practical guidance for trainers and veterinarians on how to help prevent these catastrophic injuries.
The advisory’s key findings include:
<ul>
<li>Fatal proximal forelimb (humeral and scapular) fractures accounted for 15% of training fatalities reported to HISA by Regulatory Veterinarians in 2024.</li>
<li>More than 40% of horses that experienced fatal proximal forelimb fractures that were reported to HISA had no recorded high-speed furlongs within the 60 days prior to the fracture occurring.</li>
<li>On average, horses with these fractures logged only 12.3 high-speed furlongs in the 60 days prior to injury.</li>
<li>Horses with humeral fractures averaged only 5.9 high-speed furlongs in that same timeframe.</li>
</ul>
These findings suggest that horses in early stages of training or those returning from an extended layoff may be at higher risk for fatal proximal forelimb fractures than previously recognized.
This marks the first time HISA is publicly sharing insights from its Portal, making these findings available to the broader industry to support better-informed care, promote best practices and reduce the risk of equine injury and fatality. As HISA continues to collect and analyze exercise history data from across the country, it will issue additional advisories on other injury risk patterns. This effort reflects HISA’s broader mission to proactively identify risk factors and help industry participants make racing safer for both horses and riders.
“It is HISA’s goal to substantially reduce the number of these fatalities beginning in 2025. Building awareness is the first step. This advisory reflects our commitment to data-driven safety and highlights the collective responsibility we have as an industry to intercede for at-risk horses before injuries occur,” said Dr. Jennifer Durenberger, HISA Director of Equine Safety and Welfare. “Our goal is to translate this growing body of information in our Portal into actionable guidance that can make our sport safer.”
The full advisory is available <a href="https://hisaus.org/resources/hisa-equine-health-advisory-risk-factors-and-prevention-of-proximal-forelimb-shoulder-fractures-in-thoroughbreds">here</a>. It has been distributed to all trainers and veterinarians registered in the HISA Portal and is also available on www.hisaus.org under the Resources section.

HISA Issues Equine Health Advisory on Risk Factors for Fatal Proximal Forelimb Fractures

March 2025 Newsletter

Other Announcements

2024 Annual Performance Report

March 17, 2025 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) today announced the release of its <a href="https://hisaus.org/news/2024-annual-metrics-report">2024 Annual Metrics Report</a>, reaffirming its commitment to transparency and accountability in Thoroughbred racing. The report presents key data collected in 2024 as part of HISA’s Racetrack Safety Program. Information related to HISA’s Anti-Doping and Medication Control (ADMC) Program will be released later this month by HISA’s independent anti-doping administrator, the Horseracing Integrity &amp; Welfare Unit.
In 2024, HISA continued to advance safety and welfare measures for Thoroughbred horses and riders. As <a href="https://hisaus.org/news/racing-related-fatality-rate-at-hisa-racetracks-hits-historic-low-in-2024">previously announced</a>, the 47 racetracks operating under HISA’s ADMC Program and Racetrack Safety Program recorded an aggregate racing-related fatality rate of 0.90 per 1,000 starts. The Jockey Club <a href="https://www.jockeyclub.com/Default.asp?section=Resources&amp;area=10&amp;story=1511">subsequently published</a> the 2024 data from its Equine Injury Database (EID), announcing a North American racing-related fatality rate of 1.11 per 1,000 starts. Significantly, the 2024 EID shows that racetracks in the United States that are not subject to HISA’s rules have a fatality rate of 1.76 per 1,000 starts, which is almost double the 0.90 per 1,000 starts at HISA racetracks.
“HISA has made significant progress in advancing its mandate across racetrack safety, technological innovation, uniform medication control and equine welfare,” said HISA CEO Lisa Lazarus. “HISA pursued these initiatives with input and support from the many racing stakeholders who are the backbone of the sport, and their collective efforts have led to meaningful improvements in our safety metrics. We look forward to continuing to work with the industry to make further inroads.”
The rate of 0.90 is a 35% decrease from the rate of 1.39 reported by the EID in 2021—the last full year prior to the launch of HISA’s Racetrack Safety Program—and a 27% decrease from the rate of 1.23 that HISA reported last year. It also represents a 55% decline since 2009, when the EID first began reporting such fatalities, at a rate of 2.00.
The 2024 report marks the first time in Thoroughbred racing history that nationwide data on training-related fatalities has been published in the U.S. (and, to HISA’s knowledge, internationally). By implementing standardized tracking and reporting for training-related fatalities and sharing such data on a by-state and by-racetrack basis, HISA is providing unprecedented transparency and knowledge-sharing among industry stakeholders. In 2024, racetracks operating under HISA’s rules (and the training facilities owned by them) reported 181 training-related deaths, equating to 0.50 deaths per 1,000 workouts (i.e., the official timed works of racehorses preparing for an official start). This is a conservative ratio, as HISA’s training-related data includes fatalities that occur during all training activities, not just workouts.
While it is too early to establish trends in combined racing- and training-related fatality data, transparency is a critical first step in identifying risk factors and developing targeted safety initiatives. The information collected on training-related fatalities has served to expand the already significant database HISA has built and will be instructive as the organization moves into the next phase of its data-driven efforts—identifying patterns to help racing stakeholders make more informed decisions for their horses and proposing guidance and rules designed to make training safer.
The full report can be accessed here: <a href="https://hisaus.org/news/2024-annual-metrics-report">2024 Annual Metrics Report &#8211; Horseracing Integrity and Safety Authority</a>.

HISA Releases 2024 Annual Metrics Report

Metrics Reports

2024 Annual Metrics Report

March 14, 2025 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) is pleased to announce the reappointment of Jeff Novitzky, Senior Vice President, Anti-Doping Compliance for the Ultimate Fighting Championship (UFC), to its Anti-Doping and Medication Control (ADMC) Committee.
Novitzky is an American sports executive and former federal investigator known for his extensive contributions to anti-doping enforcement. In his current role, he leads the UFC’s drug-testing and anti-doping initiatives. Prior to joining the UFC in April 2015, Novitzky was a federal agent with the U.S. Food and Drug Administration’s Office of Criminal Investigations, where he led investigations into companies suspected of illegally distributing performance-enhancing substances, including the Lance Armstrong/U.S. Postal Service Pro Cycling Team case. Before that, he conducted Internal Revenue Service investigations into some of the highest-profile anti-doping cases in professional sports history, including those involving the Bay Area Laboratory Co-operative and Barry Bonds. His efforts have significantly influenced drug-testing policies in professional sports.
“Jeff’s extensive expertise will be a tremendous asset to the ADMC Standing Committee,” said Charles Scheeler, Chair of the ADMC Standing Committee and the HISA Board of Directors. “His leadership in anti-doping enforcement and commitment to the principles of fair competition will further strengthen our mandate to promote transparency, safety and integrity in horse racing.”
The ADMC Standing Committee is composed of four independent members and three industry representatives. The committee plays a key role in advising and assisting HISA with the development of comprehensive rules and protocols for its ADMC Program, including the Prohibited Substances List, laboratory testing standards, in-competition and out-of-competition testing programs and ADMC research and educational initiatives. The daily operations of the ADMC Program are managed by the Horseracing Integrity &amp; Welfare Unit, a subsidiary of Drug Free Sport International, which works to ensure horse racing is conducted in accordance with the ADMC Program and that the welfare of horses is always prioritized when it comes to the implementation of medication rules.
As HISA welcomes back Novitzky, the organization also expresses gratitude to Dr. Jerry Yon, who stepped down from the committee on December 31, 2024, after years of dedicated service.
“We deeply appreciate Dr. Yon’s invaluable contributions to the ADMC Standing Committee,” said Lisa Lazarus, CEO of HISA. “His dedication and insight have played a pivotal role in shaping the foundation of the ADMC Program, leaving a lasting legacy that will continue to strengthen the integrity and welfare of our sport.”
The full list of ADMC Standing Committee members can be viewed online <a href="https://hisaus.org/about-us?cat=admc-committee">here</a>.

HISA Welcomes Back Jeff Novitzky to ADMC Committee

February 2025 Newsletter

February 21, 2025 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) and the Horseracing Integrity &amp; Welfare Unit (HIWU), in collaboration with the Pennsylvania State Horse Racing Commission (PSHRC), today announced that they are pursuing cases against one veterinarian and 13 trainers in connection with an organized effort to evade HISA rules designed to protect and enhance the health and safety of horses and riders.
A coordinated investigation led by the PSHRC revealed that veterinarian Dr. Allen Post Bonnell allegedly conspired with the implicated trainers from May 2023 through November 2024 to administer intra-articular injections to the joints of Covered Horses within the prohibited stand-down periods, in direct violation of HISA’s Anti-Doping and Medication Control (ADMC) and Racetrack Safety Programs—whose rules are in place to safeguard equine health and ensure fair competition.
As a result of the alleged violations, HISA and HIWU will pursue sanctions against these Covered Persons as described in HISA’s rules, including the disqualification of more than 100 horses from previous race results and subsequent forfeiture of purses, periods of Ineligibility for the Covered Persons and fines. While all horses were allegedly injected at Penn National Race Course, they participated in races at 10 different racetracks subject to HISA’s rules, across six different states.
HISA has verified that of the more than 100 unique horses alleged to have breezed or raced in violation of HISA&#8217;s intra-articular stand down times, 30% never raced again, strongly suggesting these injections were used to mask pain. Approximately 10% were observed to be lame post-race by a regulatory veterinarian. Three horses were euthanized as a direct result of injuries sustained in those races.
“This egregious breach of integrity and intentional undermining of equine welfare is a stark reminder of why rigorous oversight and enforcement are critical to the future of horse racing,” said HISA CEO Lisa Lazarus. “The health and safety of horses and jockeys are paramount, and those who deliberately put them at risk will be held accountable.”
From the inception of the ADMC Program on May 22, 2023 through July 7, 2024, HIWU enforced intra-articular injection rule violations. As of July 8, 2024, HISA has been enforcing intra-articular injection protocols under its revised Racetrack Safety Program.
Further details, including disciplinary actions and sanctions against those involved, will be released in accordance with the disclosure requirements under the Racetrack Safety Program and ADMC Program. HISA, HIWU and the PSHRC remain steadfast in their commitment to protecting the integrity of the sport and the welfare of its equine and human athletes.

HISA, HIWU Pursue Cases Against Veterinarian and 13 Trainers in Widespread Conspiracy

February 20, 2025 (Lexington, KY) &#8211; For the first time in the United States since data has been recorded, the racing-related fatality rate at racetracks subject to the Horseracing Integrity and Safety Authority’s (HISA) rules fell below 1.00 per 1,000 starts for a calendar year. In 2024, 99.91% of starts did not result in a fatality. From January 1 through December 31, 2024, 47 racetracks across 19 states operating under HISA’s rules recorded an aggregate racing-related fatality rate of 0.90 per 1,000 starts, an approximate 27% decrease from the 1.23 rate reported by HISA in 2023 and a 55% decrease from when The Jockey Club’s Equine Injury Database began reporting fatalities in 2009 at a rate of 2.00.
“It has never been clearer that Thoroughbred racing has become safer under HISA,” said HISA CEO Lisa Lazarus. “While we celebrate this progress, HISA remains committed to collaborating with industry stakeholders to further reduce fatalities and to enhance safety for horses, jockeys and all those who love and participate in the sport.”
HISA’s Racetrack Safety Program, implemented on July 1, 2022, and its Anti-Doping and Medication Control Program, implemented on May 22, 2023, have significantly strengthened safety measures nationwide by implementing uniform rules that embody best-practice standards. Key requirements include expanded veterinary protocols, pre-race inspections, laboratory harmonization, racetrack surface monitoring and uniform medication oversight. HISA also has rolled out new technologies in the last year to assist stakeholders with making informed decisions about equine athletes, including <a href="https://hisaus.org/news/hisa-introduces-hisa-horse-in-sight">HISA Horse In-Sight</a>, an innovative platform that combines a horse’s career and medical history to provide a unique and holistic view of its health and performance.
In March, HISA will release its 2024 Annual Report, which will detail racing-related fatalities over time by state and racetrack. Additionally, for the first time, the 2024 Annual Report will include full-year training-related fatality data on an aggregate, per-state and per-track basis. By implementing standardized tracking and reporting for training-related fatalities, HISA is providing unprecedented transparency and insight as part of ongoing efforts to prevent training- and racing-related fatalities across the country. This expanded dataset will enable a more comprehensive understanding of risk factors and inform targeted safety measures in both training and racing.

Racing-Related Fatality Rate at HISA Racetracks Hits Historic Low in 2024

January 2025 Newsletter

February 3, 2025 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) is pleased to announce the addition of Thoroughbred horsemen Michael Annechino, Neil Howard, Todd Mostoller and Justin Revak to its Horsemen’s Advisory Group. Formed in 2022, this body of racing industry participants provides HISA’s executive team and Standing Committees with formal feedback on the evolution of its Racetrack Safety Program and Anti-Doping and Medication Control (ADMC) Program. Its new members succeed outgoing Horsemen’s Advisory Group members Timothy Keefe, Maggi Moss, Graham Motion and Kirk Wycoff.
The Horsemen’s Advisory Group has 18 members with a wide variety of viewpoints from across the racing industry. Its membership includes trainers, owners, bloodstock agents, horsemen’s group representatives and veterinarians.
“We are grateful to Timothy Keefe, Maggi Moss, Graham Motion and Kirk Wycoff for their invaluable contributions to HISA’s mission,” said HISA CEO Lisa Lazarus. “Their unwavering dedication and keen insights have played a critical role in advancing HISA’s rules, driving meaningful progress for the industry. We are excited to welcome our new members and look forward to learning from their extensive experience as we continue to build a safer and more unified framework for Thoroughbred racing.”
The full list of the Horsemen’s Advisory Group members can be found <a title="https://horseracingintegrityandsafetyauthorityhisa.cmail20.com/t/r-l-thskihk-niietkijk-y/" href="https://horseracingintegrityandsafetyauthorityhisa.cmail20.com/t/r-l-thskihk-niietkijk-y/" data-auth="NotApplicable" data-linkindex="2">here</a>, with more information about each of the new members also available below.
Michael Annechino is an Ohio-based owner who has been involved in Thoroughbred racing since 1980. Annechino has raced across the country, having held licenses in more than 20 states, and Canada. Specializing in the claiming game, he has campaigned more than 750 horses over the past four decades. Among his wins are 17 stakes victories. Originally from New York, he was the Executive Director/Board Member of the Ohio Thoroughbred Breeders and Owners Association from 2020-2024.
Neil Howard is a Kentucky-based, lifelong horseman who retired from over two decades of service as Gainesway Farm’s general manager in 2019. He currently serves as a management consultant for various clients. He is a former commissioner of the Kentucky Horse Racing Commission and has served in a number of capacities for the thoroughbred industries&#8217; professional organizations.
Todd Mostoller is a Pennsylvania resident, currently serving as the executive director of the Pennsylvania Horsemen’s Benevolent and Protective Association. Mostoller was instrumental in the crafting of Pennsylvania’s Racehorse Development and Gaming Act, as well as the creation of New Start, a second career placement organization for retired racehorses. He is also an owner, campaigning horses under Commonwealth New Era Racing, LLC.
Justin Revak is a Minnesota-based owner and managing partner of the ownership group Rocket Wrench Racing LLC. He also serves as President of the Minnesota Horsemen’s Benevolent and Protective Association and President of the Canterbury Chaplaincy Backside Foundation.

HISA Welcomes New Members to Horsemen’s Advisory Group

Operational Bulletins

Meeting Minutes

December 19, 2024 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) today announced the members of its Veterinary Advisory Committee. The committee will commence regular meetings in early 2025 to provide feedback to HISA’s executive team and standing committees on the implementation and evolution of HISA’s rules and protocols related to veterinary care, medication, racetrack safety, equine research and other relevant issues.
Following the announcement of the Veterinary Advisory Committee’s formation on September 30, HISA has appointed 16 regulatory and private practice veterinarians from across the country. Committee members will serve staggered terms of 18 to 30 months to ensure a dynamic, evolving group and maximize opportunities for future participation.
“I would like to express my gratitude to each of the highly qualified veterinarians who have generously agreed to contribute their time and expertise to the advancement of our sport,” said HISA CEO Lisa Lazarus. “Their collective knowledge of and commitment to matters relating to equine health and welfare will be instrumental in guiding our efforts to foster a safer and more sustainable future for horse racing.”
“I am honored to welcome to the committee such a talented and dedicated group of veterinarians,” added Dr. Jennifer Durenberger, HISA Director of Equine Safety and Welfare, who will be chairing the committee. “Both clinical and regulatory veterinary knowledge and experience are essential to HISA’s mission of enhancing safety and integrity in the sport. We look forward to collaborating with our new committee members to advance horse welfare and drive scientific progress.”
Members of HISA’s Veterinary Advisory Committee are:
<ul>
<li>Dr. Kathleen Anderson</li>
<li>Dr. Ada Caruthers</li>
<li>Dr. Ashley Daniel</li>
<li>Dr. Horace (“Sam”) O. Ferguson</li>
<li>Dr. Peter Hannigan</li>
<li>Dr. Andrew Hirschy</li>
<li>Dr. Kathleen Kivi</li>
<li>Dr. Michael Manno</li>
<li>Dr. Justin McCormick</li>
<li>Dr. Martha Misheff</li>
<li>Dr. Amy Narotsky</li>
<li>Dr. Nolton Pattio</li>
<li>Dr. Kathy Picciano</li>
<li>Dr. Lindsey Porubovich</li>
<li>Dr. Lisa Santa-Emma</li>
<li>Dr. Nick Smith</li>
</ul>
To read the full biography for each member, please visit the Veterinary Advisory Committee page on HISA’s website, located <a href="https://hisaus.org/about-us?cat=veterinary-advisory-committee#our-team">here</a>.

HISA Announces Membership of Veterinary Advisory Committee

December 17, 2024 (Lexington, KY) &#8211; The Horseracing Integrity and Safety Authority (HISA) today announced the publication of its 2024 Third Quarter Metrics Report. This report provides a detailed analysis of key performance indicators related to the safety and integrity of Thoroughbred racing in the United States.
The third quarter of 2024 (July 1 – September 30) marked the third consecutive quarter of year-over-year declines in the racing-related equine fatality rate since the launch of HISA’s Anti-Doping and Medication Control (ADMC) Program, which began on May 22, 2023. The Q3 fatality rate decreased approximately 21% year-over-year, with racetracks operating under HISA’s rules reporting 0.93 racing-related equine fatalities per 1,000 starts as compared to a rate of 1.18 in the third quarter of 2023.
“The consistent year-over-year declines in the racing-related equine fatality rate are a testament to the dedication and collaboration of all stakeholders in our industry,” said HISA CEO Lisa Lazarus. “As safety and integrity continue to improve, we’re reminded that our mission to protect the well-being of horses and riders will preserve the sport for generations to come. There’s still more to achieve, but the progress so far is inspiring.”
Third Quarter 2024 Highlights
Racing-Related Equine Fatalities
<ul type="disc">
<li>Racetracks under HISA&#8217;s jurisdiction reported 0.93 racing-related fatalities per 1,000 starts in Q3 2024, approximately a 21% decrease as compared to the same period in 2023.</li>
<li>The aggregate year-to-date fatality rate for HISA racetracks (January 1 to September 30, 2024) was 0.85 per 1,000 starts, approximately a 36% decrease as compared to the same period in 2023.</li>
<li>HISA submitted public disclosure requests for racing-related fatalities in Louisiana, Texas and West Virginia and received responses after releasing its own second-quarter results.
<ul type="circle">
<li>During the second quarter of 2024, fatalities at racetracks in these non-HISA states amounted to 2.38 racing-related fatalities per 1,000 starts, more than triple the fatality rate at racetracks operating under HISA’s rules during the same period, which was 0.76 racing-related fatalities per 1,000 starts.</li>
</ul>
</li>
</ul>
Racing Participant Registration
<ul type="disc">
<li>Registrations through the HISA Portal reached approximately 35,500 Covered Persons across the categories below and 75,000 Covered Horses as of September 30, 2024.</li>
</ul>
<a href="https://hisaus.org/news/hisa-publishes-2024-third-quarter-metrics-report/2024-q3-covered-persons/" rel="attachment wp-att-5050"><img loading="lazy" decoding="async" class="size-medium wp-image-5050 aligncenter" src="https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-300x285.png" alt="" width="300" height="285" srcset="https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-300x285.png 300w, https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-1024x973.png 1024w, https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-768x730.png 768w, https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-1536x1460.png 1536w, https://bphisaweb.wpengine.com/wp-content/uploads/2024/12/2024-Q3-Covered-Persons-2048x1947.png 2048w" sizes="auto, (max-width: 300px) 100vw, 300px" /></a>
Racetrack Accreditation
<ul type="disc">
<li>HISA completed six accreditation visits in Q3 2024, bringing the total number of accreditation visits to 37 as of September 30, 2024. In Q3, HISA visited Downs at Albuquerque in New Mexico, Colonial Downs in Virginia, Ellis Park in Kentucky, Fresno California Racing Fair in California, Horseshoe Indianapolis in Indiana and Monmouth Park in New Jersey.</li>
</ul>
Veterinary Treatment Records
<ul type="disc">
<li>An average of 7,500 veterinary treatment records were uploaded daily during Q3 2024, bringing the total to 4 million records since the Racetrack Safety Program’s inception on July 1, 2022.</li>
</ul>
As the industry continues to collaborate to address challenges, HISA remains steadfast in its goal of creating a safer racing ecosystem. To view the full Q3 Metrics Report, click <a title="https://hisaus.org/news/2024-q3-metrics-report" href="https://hisaus.org/news/2024-q3-metrics-report" data-auth="NotApplicable" data-linkindex="0">here</a>. The Horseracing Integrity &amp; Welfare Unit will separately release its Q3 report for the Anti-Doping and Medication Control Program.

HISA Publishes 2024 Third Quarter Metrics Report

December 5, 2024 (Lexington, KY) – The Horseracing Integrity and Safety Authority (HISA) will aggressively defend itself against a recent lawsuit by Churchill Downs Incorporated (CDI) and The New York Racing Association, Inc. (NYRA) filed in the companies’ attempt to avoid paying their fair share of HISA’s fees (Rule 8500 Series). CDI and NYRA have refused to comply with the Assessment Methodology Rule, as approved by the Federal Trade Commission. The rule was created to properly and equitably allocate the costs of HISA’s operations to state racing commissions and/or covered persons involved with covered horse races. CDI and NYRA are the only two racing organizations subject to this rule that have refused to remit their share of fees. HISA CEO Lisa Lazarus today issued the following statement in response to the meritless lawsuit:
“HISA was established with a clear mission: to create uniformity and consistency across Thoroughbred racing. Our rules, including the Assessment Methodology Rule, were developed after thorough consideration and many opportunities for input from racing participants, and have been approved by the Federal Trade Commission. Despite this, CDI and NYRA are refusing to comply with the assessment methodology, which is designed to ensure HISA is adequately funded and able to effectively oversee the Anti-Doping and Medication Control Program and the Racetrack Safety Program, as required under the Horseracing Integrity and Safety Act.
“CDI and NYRA have both benefited greatly from HISA’s uniform safety rules, expertise and oversight, particularly over the past two years. That uniformity must extend to cost assessments as well. To do otherwise would be unfair to other tracks and industry participants who are paying their fair share. HISA will continue to uphold the standards of the sport with integrity and fairness for all racing participants. Our mission is clear, and we will not allow any parties to pick and choose which rules they follow. Every racetrack, including CDI and NYRA, must operate under the same paradigm. No one is exempt.”

HISA Responds to Lawsuit Filed by Churchill Downs and The New York Racing Association

November 19, 2024 (Lexington, KY) &#8211; The Horseracing Integrity and Safety Authority (HISA)’s Exercise-Associated Sudden Death (EASD) Working Group, formed in October of 2023 to advance research initiatives and collaborate with industry leaders on the critical issue of EASD, today announced the funding of two groundbreaking research studies.
The Working Group is made up of distinguished veterinarians and equine researchers focused on the scientific understanding and prevention of sudden, unexpected fatalities occurring during or closely following exercise in Thoroughbred racehorses.
“The EASD Working Group is working diligently to address the incidence of sudden deaths, which continue to account for a significant portion of racing fatalities. This ongoing challenge requires increased attention, which is exactly why HISA exists. We are optimistic that this group’s research will enhance our understanding and help inform policy changes that will reduce sudden fatalities and safeguard our horses,” said HISA CEO, Lisa Lazarus.
The Group is sponsoring two groundbreaking studies, one of which seeks to identify biomarkers that could be used to identify horses at high risk of EASD, while the other focuses on a comprehensive monitoring program using wearable technology. Both are aimed at developing practical screening tools and reducing EASD occurrences.
University of Minnesota Biomarker Research
Dr. Sian Durward-Akhurst of the Department of Veterinary Clinical Sciences, University of Minnesota, is working on a multi-omics approach to prediction of EASD in Thoroughbred racehorses by identifying biomarker differences between healthy Thoroughbred racehorses and those that succumb to EASD.
The lab’s long-term goal is to develop a non-invasive screening test to identify horses at increased risk of EASD. These horses can then be monitored closely, and recommendations can be made for when they are safe to train and race with the goal of reducing the frequency of EASD. Additionally, if there are horses that are considered at high risk of EASD but never have issues, it will be possible to look for protective measures to which those horses may be exposed.
Racing authorities and racetracks are currently being recruited to collect samples from horses that have succumbed to EASD and healthy controls.
University of Pennsylvania and University of Minnesota Wearable Device Monitoring Program
Dr. Cris Navas of New Bolton Center, University of Pennsylvania, and Dr. Durward-Akhurst of the Department of Veterinary Clinical Sciences, University of Minnesota, have begun an Exercise-Associated Sudden Death monitoring pilot program. 
Collaborating trainers are asked to place the Arioneo Equimetre wearable devices on each horse during training weekly for 4-6 months. For each of the training sessions, ECG, heart rate, stride characteristics (rate, length, symmetry [for trot] and regularity), speed, distance, duration and the relationships and progression of these variables are measured. Enrollment is free and the data is kept confidential between researchers, trainers and the veterinary team of each trainer.
In the first eight weeks of the study, they have recruited 193 Thoroughbred racehorses across racetracks in Delaware, Florida, Kentucky, Maryland and Minnesota, and 493 training sessions have been recorded so far. They are planning to record 250 horses for the initial phase of the study, giving approximately 4,000 training sessions for analysis. 
These research projects are ongoing. The initial pilot studies are expected to be completed by December 2025. If data collection and analysis are proven to be feasible in the North American racetrack setting, the goal is to enroll a large enough number of racehorses to allow the identification of risk factors for EASD. If accurate risk factors are identified, these will used to implement prevention programs to reduce the frequency of EASD.
About the EASD Working Group
The EASD Working Group is comprised of renowned experts in veterinary medicine and pathology:
<ul type="disc">
<li class="x_MsoNormal">Sian Durward-Akhurst, BVMS, PhD, DACVIM</li>
<li class="x_MsoNormal">Craig Goldblatt, DVM</li>
<li class="x_MsoNormal">Julie Engiles, VMD, DACVP</li>
<li class="x_MsoNormal">Lynn Hovda, DVM, PhD, ACVIM</li>
<li class="x_MsoNormal">Laura Kennedy, DVM, DACVP</li>
<li class="x_MsoNormal">Molly McCue, DVM, PhD, DACVIM</li>
<li class="x_MsoNormal">Cris Navas, LV, PhD, DACVIM</li>
<li class="x_MsoNormal">Allen Page, DVM, PhD</li>
<li class="x_MsoNormal">Mary Robinson, DVM, PhD</li>
<li class="x_MsoNormal">Francisco Uzal, DVM, PhD, DACVP</li>
</ul>
These veterinarians are focused on EASD monitoring, on-track emergency response plans, uniform heart sampling, advanced postmortem testing and necropsy protocols. Together, they aim to develop and implement practical strategies to understand better, monitor and reduce the risk of EASD.
 
About the Horseracing Integrity and Safety Authority
Subject to Federal Trade Commission oversight, the Horseracing Integrity and Safety Authority is charged with recommending and implementing uniform safety and integrity rules in Thoroughbred racing. HISA is implementing, for the first time, a national, uniform set of rules applicable to every Thoroughbred racing participant and racetrack facility. HISA is comprised of two programs: the Racetrack Safety Program, which went into effect on July 1, 2022, and the Anti-Doping and Medication Control (ADMC) Program, which went into effect on May 22, 2023.
The Racetrack Safety Program includes operational safety rules and national racetrack accreditation standards that seek to enhance equine welfare and minimize equine and jockey injury. The Program expands veterinary oversight, imposes surface maintenance and testing requirements, enhances jockey safety, regulates riding crop use and implements voided claim rules, among other important measures.
The ADMC Program includes a centralized testing and results management process and applies uniform penalties for violations efficiently and consistently across the United States. These rules and enforcement mechanisms are administered by an independent agency, the Horseracing Integrity and Welfare Unit (HIWU), established by Drug Free Sport International (DFS). HIWU oversees testing, educates stakeholders on the Program, accredits laboratories, investigates potential ADMC violations and enforces the ADMC Program.
MEDIA CONTACT
Mandy Minger
<a id="LPlnk233618" title="mailto:mandy.minger@hisaus.org" href="mailto:mandy.minger@hisaus.org" data-linkindex="0">mandy.minger@hisaus.org</a>
917-846-8804

HISA Exercise-Associated Sudden Death Working Group Announces Funding of Groundbreaking Research Studies

NOVEMBER 4, 2024 &#8211; Following a resolution proposed by HISA’s Horsemen’s Advisory Group, which was also supported by the Thoroughbred Horsemen&#8217;s Association, HISA’s Board of Directors announces the following policy change effective immediately regarding the Anti-Doping and Medication Control (ADMC) Program and the imposition of Provisional Suspensions of Covered Persons. Commencing immediately, the HISA Board has requested that the Horseracing Integrity &amp; Welfare Unit (HIWU) limit the circumstances under which they exercise their discretion to impose a Provisional Suspension on Covered Persons.
The HISA Board has determined that further analysis and review on the issue of Provisional Suspensions is necessary to determine whether any modifications to the current rules are appropriate. While this review takes place, the HISA Board requests that HIWU impose Provisional Suspensions only under circumstances where (i) a Covered Person has more than one horse test positive for the same Banned Substance; (ii) a barn search leads to the discovery of the same Banned Substance for which the Covered Person is being charged under the ADMC program; and/or (iii) the alleged violation presents a substantial risk to the integrity of racing and/or the welfare of horses. Consequently, all Provisional Suspensions that do not fall within any of these defined categories will be lifted today, November 4, 2024.
The lifting of the Provisional Suspension is not a stay of the Equine Anti-Doping Notice or Charge or the ADMC Program proceedings with respect to the matter, with the exception of Presence cases for Metformin. HIWU will be moving forward with these matters under the applicable ADMC Program Rules.

HISA Announcement Regarding Provisional Suspensions

Attention Attending Veterinarians,
HISA has introduced a new treatment record type: Mandatory Attending Veterinarian Inspection.
<ol>
<li>A ‘Cleared to Work’ Result indicates that a horse has been inspected by an Attending Veterinarian and has been found fit to work.</li>
<li>A ‘Cleared to Race’ Result indicates that a horse has been inspected by an Attending Veterinarian and has been found fit to race,</li>
</ol>
You also have the option to not clear the horse, which will affect the Can-Work and Can-Race status of the horse.
Resources
An educational video demonstrating how to enter this new type of treatment record is available <a href="https://hisausregs.org/reg-document-video/958504508">here</a>.
If you have any questions, please contact our Help Desk at 1-877-513-2919, and we will be happy to help you.

New Treatment Record Type: Mandatory Attending Veterinarian Inspection

Attention:
We are excited to that announce a new “Windows-Like” experience will now be available for managing Track Files. This feature offers a familiar Windows File Explorer interface where documents are organized into folders and subfolders. Depending on your role at the track, you may have:
<ul>
<li>Full access to track documentation</li>
<li>Limited access based on document type and your permissions</li>
</ul>
We have created an <a href="https://hisausregs.org/reg-document-video/962288082">educational video</a> to help navigate these new features.
For further questions, please reach out to the HISA Help Desk at 1-877-513-2919, and we will be happy to assist you.

New File Storage System in Track Details

Attention Owners and Trainers,
HISA is introducing new functionality in the portal that allows you to register an entity. If you own or train a horse as part of an LLC, syndicate or other entity ownership, you can now register that entity. Once registered, you can add horses to the entity, either at the time of registration or by transferring ownership from an individual to the entity.
Each ownership entity must list the default designated owner, who will serve as the primary contact. Additionally, there is an option to add an “Entity Administrator,” who will manage the acceptance of registered Individuals into and out of the entity.
Resources
To help you navigate this new feature, we have created some educational videos to guide you:
<a href="https://hisausregs.org/reg-document-video/966754818">How to Register an Entity through the HISA portal</a>
<a href="https://hisausregs.org/reg-document-video/966755052">How to Register a Horse with an Entity as the Designated Owner</a>
<a href="https://hisausregs.org/reg-document-video/962262487">How to transfer a Horse to an Ownership Entity</a>
<a href="https://hisausregs.org/reg-document-video/962287675">Overview of Roles within an Ownership Entity</a>
If you have any questions, please contact our Help Desk at 1-877-513-2919, and we will be happy to assist you.

Introducing Ownership Entities in the HISA Portal

Attention Portal Users,
We are updating the display of the CAN-RACE shield next to a horse in the portal. Beginning June 24, 2024, the Can-Work/Can-Race shield will now display in red, green or two-toned. For example, a shield that is green on top and red on the bottom signifies that the horse is cleared to work but cannot race.
<img loading="lazy" decoding="async" class="alignnone size-medium wp-image-4162" src="https://bphisaweb.wpengine.com/wp-content/uploads/2024/06/CanRaceCanWorkShields-300x278.png" alt="" width="300" height="278" srcset="https://bphisaweb.wpengine.com/wp-content/uploads/2024/06/CanRaceCanWorkShields-300x278.png 300w, https://bphisaweb.wpengine.com/wp-content/uploads/2024/06/CanRaceCanWorkShields.png 483w" sizes="auto, (max-width: 300px) 100vw, 300px" />
Hover your mouse over the shield to learn more about the meaning of the colors and their placement on the shield icon.
Watch this <a href="https://hisausregs.org/reg-document-video/960391312">short video</a> for more information related to the Can-Work/Can-Race shield.
If you have any questions, please call our Help Desk at 1-877-513-2919, and we will be happy to assist you.
&nbsp;
The HISA Team
&nbsp;

Changes to the Can-Race Shield in the HISA Portal

Hello. We are reaching out to inform you of a change to the claiming process in the HISA Portal. This change will be effective on Monday, June 24, 2024.
The new process will ensure that all claims and voided claims are recorded in accordance with HISA’s Racetrack Safety Program.
It is crucial that claims are processed in a timely manner so that all information associated with a Covered Horse is accurate and up to date.
In the event that a claim is deemed an automatic void (horse is euthanized, vanned off the racetrack, or critically injured), the claim must still be processed through the HISA Portal and then subsequently voided to ensure the horse’s claiming history is complete.
Benefits of the changes:
<ul>
<li>Claiming Clerks will be able to:
<ul>
<li>Process multiple claims in one session. It’s way more efficient than the previous method.</li>
<li>Void a claim within the same session. It’s no longer a separate step you have to take.</li>
<li>Process claims faster.</li>
</ul>
</li>
<li>New Designated Owners and Responsible Persons will have an easier time entering the claimed horse into a race if all the information is correct in the HISA Portal.</li>
</ul>
Resources:
We have produced educational materials (<a href="https://hisausregs.org/reg-document-video/957194073">Video</a> &amp; <a href="https://hisa-resources-public.s3.amazonaws.com/the-claiming-process-visual-guide.pdf">Visual Guide</a>) to help you learn about this new process. If you require additional assistance, please contact the Help Desk at 1-877-513-2919 and we will be happy to help you.
We are also hosting a virtual training session on Tuesday, June 25, 2024, at 12 pm Eastern Standard Time:
Topic: New Claiming Process
Time: Jun 25, 2024 12:00 PM Eastern Time (US and Canada)
&nbsp;
Join Zoom Meeting
<a href="https://us06web.zoom.us/j/84966750752?pwd=uwzftfisSsdWmpBv9ht01p7naVZIQF.1">https://us06web.zoom.us/j/84966750752?pwd=uwzftfisSsdWmpBv9ht01p7naVZIQF.1</a>
&nbsp;
Meeting ID: 849 6675 0752
Passcode: 612532
&nbsp;
&#8212;
&nbsp;
One tap mobile
+16469313860,,84966750752#,,,,*612532# US
+19292056099,,84966750752#,,,,*612532# US (New York)
&nbsp;
Thank you for your continued support,
The HISA Team

Changes to HISA Portal Claiming Process

This afternoon, the Louisiana State Racing Commission held an Emergency Public Meeting at which the Commission voted to rescind in full the emergency updates to Louisiana’s controlled medication schedule for thoroughbred racing, which reportedly were set to take effect tomorrow in Louisiana (the “Emergency Rule”).  With the complete rescission of the Emergency Rule, the Horseracing Integrity and Safety Authority, Inc. (“HISA”) will not require Covered Horses shipping from Louisiana to a HISA jurisdiction to be placed on the HISA Veterinarians’ List as medically compromised and unfit to race as announced in the June 5, 2024 Memorandum.  HISA appreciates the Commission’s willingness to reconsider this important matter.

Update to HISA’s June 5th Memorandum

JUNE 4, 2024 &#8211; Following the recommendation of the Anti-Doping and Medication Control (“ADMC”) Standing Committee, the Board of Directors of the Horseracing Integrity and Safety Authority (“HISA”) announces the following policy change effective immediately regarding the ADMC Program with respect to the Banned Substance metformin. Commencing immediately, the HISA Board has requested that HIWU defer active Provisional Suspensions for metformin positives. 
“In line with HISA’s Anti-Doping and Medication Control requirements, metformin is included in the Prohibited Substances List because there is no recognized therapeutic use for the substance in horses involved in Thoroughbred racing. In addition, HIWU has intelligence that some horsemen may be using metformin to try and gain a performance advantage. However, there is limited scientific information available regarding the substance’s use in horses.  The HISA Board feels that further expert analysis on the topic is necessary to determine if any refinement of HISA’s rules is appropriate,” said Charles Scheeler, Chairman of the HISA Board.   
Consequently, HISA and HIWU have asked the Racing Medication &amp; Testing Consortium’s (RMTC) Scientific Advisory Committee (SAC) to conduct a review of the available science relating to metformin. Following RMTC’s Board of Director’s approval, any conclusions drawn, and guidance produced regarding the SAC’s review will be shared with HISA’s ADMC Committee. Once the RMTC Scientific Advisory Committee completes its work, which we expect will take a few months, the ADMC Committee and the HISA Board will determine whether any policy changes regarding metformin should be submitted to the Federal Trade Commission for approval. 
In this interim period, metformin remains on the Prohibited Substances List and, as such, regardless of the source and/or the existence of any mitigating circumstances, any ADMC Program violation resulting from an Adverse Analytical Finding for metformin will result in the automatic disqualification of race results of the relevant Covered Horse. The deferral of Provisional Suspensions is only applicable to the Responsible Person; Covered Horses that test positive for metformin are still subject to a Provisional Suspension.  
HISA is grateful for the feedback from all industry constituents, especially the Horsemen’s Advisory Group, as we continue to refine our regulatory program to make horse racing safer and fairer for all.

HISA Announcement Regarding Metformin

Background:  Current ADMC rules include a rule adopted from the World Anti-Doping Code requiring that any Responsible Person (i.e., trainer) whose Covered Horse tests positive for a Banned (doping) Substance be Provisionally Suspended while his/her case is being processed.  A Provisional Suspension does not in any way change the presumption of innocence and is not an early determination of guilt.  Instead, it is intended as a precaution to safeguard the integrity of the sport, horse welfare, and the rights of rule-abiding trainers.  Provisional Suspensions have been instrumental in protecting the integrity of other sports and were introduced into horseracing for that reason.
Discussion: Last Friday, HIWU was informed that a split (B) sample did not confirm the original   Laboratory finding, and, accordingly, pursuant to the ADMC regulations, HIWU dismissed the violation against a trainer who had been Provisionally Suspended 20 days earlier.  This raised concerns regarding the imposition of Provisional Suspensions at this early stage of the ADMC Program’s rollout. Consequently, HISA’s ADMC Committee, which has oversight of the HISA ADMC rules, held a meeting and decided to make various policy decisions regarding the imposition of Provisional Suspensions under the ADMC Program.  Various proposals received from horsemen’s groups were considered during the course of these discussions.
Policy Change:  The following policy changes will be effective immediately and shall apply
to any Responsible Person Provisionally Suspended following a positive test for a Banned
Substance:
<ol>
<li>Any Responsible Person who requests that the B Sample be analyzed following a positive test for a Banned Substance shall be eligible for postponement of the effective date of the Provisional Suspension until such time as the B Sample result is returned. If the B Sample confirms the A Sample, the Responsible Person shall be Provisionally Suspended upon Notification of the B Sample confirmation, except that the Responsible Person shall not be required to scratch any Covered Horses entered to race prior to Notification of the B Sample confirmation. However, the Responsible Person shall not be entitled to enter any Covered Horses to race subsequent to Notification;</li>
<li>Any Responsible Person who does not request the B Sample analysis shall be Provisionally Suspended upon such election, except he/she shall not be required to scratch any Covered Horses entered to race prior to Notification of the A Sample positive finding. However, the Responsible Person shall not be entitled to enter any Covered Horses to race subsequent to Notification;</li>
<li>Any Responsible Person with more than one horse that tests positive for the same Banned Substance within a six (6) month-period or who has received notice of another potential violation relating to a Banned Substance (e.g., possession, use) shall not be eligible for delayed imposition of a Provisional Suspension as set forth in paragraph 1 above;</li>
<li>Covered/Responsible Persons will continue to be Provisionally Suspended upon the notice of the A Sample result if the result involves the detection of the following Banned Substances:</li>
</ol>
3,4- methylenedioxypyprovalerone                                Methylphenidate;
  (MDPV, Bath Salts);                                                            Mitragynine;
Alpha-pyrrolidinovalerophenone                                     Myo-inositol trispyrophosphate (ITPP);
  (Alpha PVP);                                                                          Nikethamide;
Amphetamines (e.g., Methamphetamine,                    Opioids (natural and synthetic) and
  Cathinone, Mephentermine, Methcathinone);           opioid agonists (e.g., apomorphine,
Benzylpiperazine (BZP);                                                         hydrocodone, hydromorphone,
Chlorpromazine;                                                                      oxycodone);
Erythropoietin (EPO) and EPO mimetics;                       Pentylenetetrazol;
Ethylphenidate;                                                                     Phencyclidine (PCP);
Etorphine;                                                                                Phendimetrazine;
Fentanyl and Fentanyl analogs;                                        Phenmetrazine;
Mazindol;                                                                                 Strychnine;
Meldonium;                                                                            Synthetic cannabinoids;
Metaraminol;                                                                         Tetrahydrocannabinol (THC); and
Methaqualone;                                                                      Venoms and toxins (e.g., alpha
Methylhexanamine;                                                               cobratoxin, ziconotide, botulinum
                                                                                                       toxin)
<ol start="5">
<li>During a Provisional Suspension, which is not a Final Suspension, Covered/Responsible Persons may engage in caring for and exercising their Covered Horses, except they cannot breeze or race Covered Horses registered to them. Should they want any Covered Horses to breeze or race, they must transfer those horses to another Responsible Person (i.e., trainer) in a bona fide transfer approved by the stewards. If the Responsible/Covered Person is an Owner, ownership of the Covered Horse must be transferred in order for it to be eligible to breeze or race.   In addition, Covered/Responsible Persons: (i) must take down or cover any personal signage bearing their name or related to their operations where the Covered Horses are located at the racetrack; (ii) cannot claim Covered Horses or bring new Covered Horses into their barn; and (iii) cannot be employed in any capacity involving Covered Horses (including, but not limited to, acting as an agent for an Owner of Covered Horses or working as an exercise rider for Covered Horses.)</li>
</ol>
Additional Notes:
<ul>
<li>The Policy Change shall also be applied to any currently suspended Responsible Persons. HIWU will be in contact with all those currently Provisionally Suspended to explain next steps.</li>
<li>The Responsible/Covered Person must pay for the B Sample analysis within seven (7) calendar days of requesting it. In cases of financial hardship, and upon the demonstration of such hardship, the Covered Person may be entitled to a payment plan to cover the cost of B Sample analysis.</li>
<li>This new Policy will remain in effect for so long as the ADMC Committee deems appropriate. Should the ADMC Committee decide at some future date to abandon or modify it, the industry will receive at least thirty (30) days’ advance notice.</li>
</ul>
Public Reporting under the ADMC rules will continue to occur at the time of the EAD Notice of the A Sample positive test.

Announcement by HISA & HIWU Regarding Provisional Suspensions

DO YOU WANT TO HAVE THE B SAMPLE ANALYZED?
1. YES. • This means that your Provisional Suspension will not start until your B Sample result comes back. During this time, you may continue to train and race your horses without interruption. • You must pay the B Sample analysis fee ($2,000) within 7 calendar days of requesting it. (In cases of financial hardship, a payment plan may be available.) • If your B Sample result does not confirm the A Sample finding(s), the case against you is dismissed and you are refunded the $2,000 for the B Sample analysis. • If your B Sample result confirms the A, you will be allowed to race any horses entered prior to Notification of the B sample confirmation. However, in all other respects, your Provisional Suspension goes into effect when you are notified of the B sample results.
2. NO. You may race any horses entered to race prior to Notification of the positive test. However, in all other respects, your Provisional Suspension goes into effect when you either waive your right to have the B sample tested or do not notify HIWU of your decision within 5 days of being notified of the A sample result.
WHAT HAPPENS WHEN YOUR PROVISIONAL SUSPENSION GOES INTO EFFECT?
You and your staff can continue looking after the horses under your care; however, these horses cannot breeze or be entered to race unless they are transferred to another Responsible Person (i.e., trainer) in a bona fide transfer approved by the stewards. If you are also an Owner, the ownership of your horse (no matter how small) must be transferred in order for the horse to be eligible to breeze or race. You are also subject to the following: (i) you must take down or cover any personal signage bearing your name or related to your operations where horses are located at the racetrack; (ii) you cannot claim horses or bring new horses into your barn; and (iii) you cannot be employed within the Thoroughbred horseracing industry in any other capacity where you come into contact with Covered Horses (including, but not limited to, acting as an agent for an Owner or working as an exercise rider.) After the imposition of the Provisional Suspension, you can request a Provisional Suspension hearing (limited to the issue of whether to lift the suspension) or a Final Hearing to conclude your case as soon as possible.

What Are Your Options if Your Horse Tests Positive for a Banned Substance?

December 2024 Newsletter

November 2024 Newsletter

October 2024 Newsletter

August/September 2024 Newsletter

July 2024 Newsletter

May/June 2024 Newsletter

2024 Q3 Metrics Report

2023 Annual Metrics Report

2024 Q2 Metrics Report

2024 Q1 Metrics Report

Dec 4, 2024: Racetrack Safety Committee Meeting Minutes

Nov 13, 2024: Racetrack Safety Committee Meeting Minutes

Nov 6, 2024: Racetrack Safety Committee Meeting Minutes

Oct 16, 2024: Racetrack Safety Committee Meeting Minutes

Oct 2, 2024: Racetrack Safety Committee Meeting Minutes

Sep 25, 2024: Racetrack Safety Committee Meeting Minutes

Sep 18, 2024: Racetrack Safety Committee Meeting Minutes

Sep 11, 2024: Racetrack Safety Committee Meeting Minutes

Aug 28, 2024: Racetrack Safety Committee Meeting Minutes

Aug 14, 2024: Racetrack Safety Committee Meeting Minutes

HISA 2024-2029 Final Strategic Plan

Last week, HISA and the Jockeys&#8217; Guild co-hosted the first Jockey Health and Wellness DC fly-in. We welcomed participants from across the United States to gather in the nation&#8217;s Capital for conversations on the physical and mental well-being of jockeys at a critical time in horse racing. Participants had the opportunity to meet with their Congressional representatives to express both their love for racing and the unique circumstances they face as athletes and family members in a fast-paced industry.

Event Recap: Jockey Health and Wellness DC Fly-In

The Horseracing Integrity and Safety Authority is seeking informal public comment on proposed modifications to the Assessment Methodology Rule (Rule 8500 Series). A draft revised Assessment Methodology Rule in pdf redline compare format is available <a href="https://bphisaweb.wpengine.com/wp-content/uploads/2024/09/Redline-Proposed-Modifications-to-Assessment-Methodology-Rule-9.18.2024_V3.pdf">here</a>. The redline compares the new version to the version submitted to and approved by the FTC on January 9, 2023. We are seeking input on the proposed modifications. Please send your feedback directly to Sam Reinhardt at <a href="mailto:Samuel.Reinhardt@hisaus.org" data-linkindex="0">Samuel.Reinhardt@hisaus.org</a> no later than Monday, September 30, 2024. If possible, please provide your comments in a single Word document.

Proposed Modifications to the Assessment Methodology Rule

The Horseracing Integrity and Safety Authority is seeking informal public comment on a proposed new set of supplemental rules relating to topics such as cleanliness and security of receiving barns, the number and location of restrooms on the backside, disclosure of consumption of Prohibited Substances, and entering a horse on the Veterinarians’ List while awaiting the results of a blood sample collection. A clean version of the supplemental rules is available <a href="https://bphisaweb.wpengine.com/wp-content/uploads/2024/09/Draft-Supplemental-Rules-9.18.2024.pdf">here</a>. Please send your feedback directly to Sam Reinhardt at <a href="mailto:Samuel.Reinhardt@hisaus.org" data-linkindex="0">Samuel.Reinhardt@hisaus.org</a> no later than Monday, September 30, 2024. If possible, please provide your comments in a single Word document.

Proposed Supplemental Rule Series

Set forth below is HISA’s proposed 2025 budget. If you would like to submit comments to HISA on any aspect of the planned 2025 budget, please email <a id="LPlnk974409" href="mailto:Samuel.Reinhardt@hisaus.org" data-linkindex="0">Samuel.Reinhardt@hisaus.org</a> no later than 12:00 p.m. ET on Monday, July 22, 2024. HISA will post any pertinent comments it receives on its website. Comments will be posted <a href="https://bphisaweb.wpengine.com/wp-content/uploads/2024/07/Pertinent-Comments-Received-Regarding-HISA-2025-Proposed-Budget.pdf">here</a>.

HISA 2025 Proposed Budget

HISA CEO Lisa Lazarus Addresses 2023 Global Symposium on Racing

Linked below are proposed revisions to Rule Series 1000, 3000, 4000, 5000, 6000 and 7000 of HISA’s Anti-Doping and Medication Control Program in clean and red-lined format. If you would like to submit feedback or propose changes, please email <a id="LPlnk588394" href="mailto:feedback@hisaus.org" data-linkindex="0">feedback@hisaus.org</a> no later than 12:00 p.m. ET on Tuesday, October 10, 2023.
Any proposed rules changes will ultimately require Federal Trade Commission (FTC) review and approval before being implemented. Until this time, the current version of the Anti-Doping and Medication Control rules, implemented May 22, 2023, remain in full effect.
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/1000.-General-Provisions-September-21-2023.pdf">Clean 1000 &#8211; General Provisions</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/3000.-Protocol-September-21-2023.pdf">Clean 3000 &#8211; Protocol</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/4000.-Prohibited-List-incl-TD-September-21-2023.pdf">Clean 4000 &#8211; Prohibited List</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/5000.-Testing-and-Investigations-Standards-September-21-2023.pdf">Clean 5000 &#8211; Testing and Investigation Standards</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/6000.-Laboratory-Standards-September-21-2023.pdf">Clean 6000 &#8211; Laboratory Standards</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/7000.-Arbitration-Rules-September-21-2023.pdf">Clean 7000 &#8211; Arbitration Rules</a>
&nbsp;
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-1000.-General-Provisions-9.21.23-v-current.pdf">Redline 1000 &#8211; General Provisions</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-3000.-Protocol-9.21.23-v-current.pdf">Redline 3000 &#8211; Protocol</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-4000.-Prohibited-List-incl-TD-9.21.23-v-current.pdf">Redline 4000 &#8211; Prohibited List</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-5000.-Testing-and-Investigations-Standards-9.21.23-v-current.pdf">Redline 5000 &#8211; Testing and Investigation Standards</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-6000.-Laboratory-Standards-9.21.23-v-current.pdf">Redline 6000 &#8211; Laboratory Standards</a>
<a href="https://bphisaweb.wpengine.com/wp-content/uploads/2023/09/Redline-7000.-Arbitration-Rules-9.21.23-v-current.pdf">Redline 7000 &#8211; Arbitration Rules</a>
&nbsp;

Proposed Changes to the Anti-Doping and Medication Control Program

Below are proposed revisions to the Rule 9000 Series (Registration) in a red- lined format showing proposed changes. If you would like to submit feedback or propose changes, please email <a href="mailto:feedback@hisaus.org" data-linkindex="0">feedback@hisaus.org</a> no later than noon ET on Friday, September 15, 2023.  Any proposed rules changes will ultimately require Federal Trade Commission review and approval before being implemented. Until this time, the current version of the Registration Rules remains in full effect.

Proposed Redline Changes to the Rule 9000 Series (Registration)

Below are proposed revisions to the Rule 80000 Series (Enforcement) in a red- lined format showing proposed changes. If you would like to submit feedback or propose changes, please email feedback@hisaus.org no later than noon ET on Tuesday September 5, 2023.
Any proposed rules changes will ultimately require Federal Trade Commission review and approval before being implemented. Until this time, the current version of the Enforcement Rules remain in full effect.

News

April 2025 Newsletter

HISA Issues Equine Health Advisory on Risk Factors for Fatal Proximal Forelimb Fractures

March 2025 Newsletter

2024 Annual Performance Report

HISA Releases 2024 Annual Metrics Report

2024 Annual Metrics Report

HISA Welcomes Back Jeff Novitzky to ADMC Committee

February 2025 Newsletter

HISA, HIWU Pursue Cases Against Veterinarian and 13 Trainers in Widespread Conspiracy

Racing-Related Fatality Rate at HISA Racetracks Hits Historic Low in 2024

January 2025 Newsletter

HISA Welcomes New Members to Horsemen’s Advisory Group

Media Resources

HISA Stewards Rulings

HIWU

Rule FAQs

Press Contact

HISA Press Releases Subscription

HISA Data Disclosure Policy